James H Boehmler1, Benjamin L Judson, Steven P Davison. 1. Department of Plastic Surgery, Georgetown University Hospital, PHC Bldg, 3800 Reservoir Rd, First Floor, Washington, DC 20007. jayboehmler@mac.com
Abstract
OBJECTIVE: To illustrate the potential reconstructive opportunities that the Endotine suspension devices can provide for patients with soft tissue ptosis secondary to facial nerve dysfunction, posttraumatic deformity, and postablative deformity. METHODS: A review was performed of 23 Endotine midface and eyebrow suspension devices in 10 patients with facial nerve sacrifice, facial trauma, or tumor extirpation. RESULTS: A total of 12 midface and 11 eyebrow suspension devices were used in 10 patients. All patients had improvement in soft tissue support and contour. The mean follow-up time was 10 months (range, 1-24 months). No major complications were noted. One patient had recurrent cellulitis secondary to maxillary sinusitis, and another had recurrent cellulitis that responded to treatment with intravenous antibiotics. The Endotine midface device was resistant to infection and did not require removal in either case. One patient requested revision surgery for resuspension of the eyebrow. CONCLUSIONS: The Endotine midface and eyebrow suspension devices have been shown to be excellent methods of fixation in cosmetic eyebrow-lifts and midface-lifts. We have demonstrated that the Endotine device may be a good reconstructive option for patients with soft tissue ptosis in a multitude of scenarios.
OBJECTIVE: To illustrate the potential reconstructive opportunities that the Endotine suspension devices can provide for patients with soft tissue ptosis secondary to facial nerve dysfunction, posttraumatic deformity, and postablative deformity. METHODS: A review was performed of 23 Endotine midface and eyebrow suspension devices in 10 patients with facial nerve sacrifice, facial trauma, or tumor extirpation. RESULTS: A total of 12 midface and 11 eyebrow suspension devices were used in 10 patients. All patients had improvement in soft tissue support and contour. The mean follow-up time was 10 months (range, 1-24 months). No major complications were noted. One patient had recurrent cellulitis secondary to maxillary sinusitis, and another had recurrent cellulitis that responded to treatment with intravenous antibiotics. The Endotine midface device was resistant to infection and did not require removal in either case. One patient requested revision surgery for resuspension of the eyebrow. CONCLUSIONS: The Endotine midface and eyebrow suspension devices have been shown to be excellent methods of fixation in cosmetic eyebrow-lifts and midface-lifts. We have demonstrated that the Endotine device may be a good reconstructive option for patients with soft tissue ptosis in a multitude of scenarios.
Authors: Jared Johnson; Houmehr Hojjat; Michael T Chung; Khashayar Arianpour; Hani Rayess; Robert Eckert; Michael Carron Journal: Plast Surg (Oakv) Date: 2020-02-18 Impact factor: 0.947